Angina-Like Chest Pain as a Symptom of Digestive Tract Disorders by Jacek Budzyński
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1. Introduction 
Chest pain is a common problem in health care, especially due to its prevalence, the 
utilization of resources according to the cost of medical procedures, and diagnostic process 
difficulties. Precordial discomfort occurs in 13-30% of the adult population per year (Cayley, 
2005; Dickman & Fass, 2006; Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; Fass, 2008; 
Fass & Navarro-Rodriguez, 2008; Laird et al., 2004; Ruigómez et al., 2006, 2009), and in 20-
40% population during their lifetime (Ruigómez et al., 2006, 2009). About 1.5-5% of the 
general population seeks a primary care doctor consultation because of chest pain episodes 
(Cayley, 2005; Erhardt et al, 2002; Eslick, 2008; Fox, 2005; Sheps et al., 2004). Moreover, it is 
the cause of 634,000 per year cardiologist consultations in the US (Mant et al., 2004), 5% of 
visits to emergency departments in the UK, and 40% of non-surgical emergency admissions 
mainly due to acute coronary syndrome suspicion (Ruigómez et al., 2006). Among these 
patients, only in 15-40% was ischaemic heart disease (IHD) diagnosed on discharge and 
features of myocardial infarction presented in only 8-10% (Dickman & Fass, 2006; Liuzzo et 
al., 2005). The analysis by Hollander et al. (2007) has also shown that among patients 
admitted due to acute coronary syndrome suspicion, myocardial infarction was confirmed 
in only 4%. Moreover, it has been known for a number of years that about 10-36% of all 
patients who qualify for coronarography have a normal coronary angiogram (Dickman & 
Fass, 2006; Dobrzycki et al., 2005; Eslick et al., 2005; Eslick, 2008]. These data corroborate the 
most recent study by Patel et al. (2010), who conclude that the diagnostic yield of elective 
coronary angiography (about 20% of all procedures) amounted only to 38% (60% did not 
influence patients’ treatment), in spite of almost 70% of the patients undergoing elective 
coronary angiography having had positive findings on non-invasive examination (resting 
electrocardiography, echocardiography, computed tomography, or stress testing). They 
were also consistent with my recent work, which, among other things, has shown that 
exercise-provoked chest pain was accompanied by significant ST interval depression in 
about 60% of subjects with normal coronary angiogram, and 40% of subjects with significant 
coronary artery narrowing did not present ischaemic-like ECG changes (Budzyński, 2010c). 
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The above-mentioned data can be summarized as follows:  
 non-invasive diagnoses of chest pain and qualification for coronary angiography and 
percutaneous procedures are still not perfect;  
 the most frequent causes of this symptom do not originate in the cardiovascular system; 
and 
 symptom sources other than cardiac should be taken into account more frequently.  
On the other hand, these conclusions should not change the prevailing principle that each 
chest pain episode must be recognized as a potential alarm symptom; the exclusion of life-
threatening conditions, including ischaemic heart disease, should remain the basis of chest 
pain diagnostic procedures. For this reason, it seems a better solution even to overuse coronary 
angiograms or coronary artery calcification scores (CAC) using multi-slice computer 
tomography, than miss the detection of severely ill patients. However, it should also always be 
taken into consideration that invasive cardiological diagnostic procedures give the most 
benefits to patients with acute chest pain episodes, and in patients with recurrent symptoms, 
extracardiac sources ought to be more frequently considered (Patel et al., 2010).  
It is possible that changes in diagnostic algorithms of chest pain diagnosis and therapy not 
only decrease the prevalence of this symptom, but might also decrease the costs of health 
care. Such reductions would be considerable, as the medical procedures connected with 
chest pain symptoms utilize a noticeable part of health care resources. The annual cost of the 
medical care of patients with recurrent chest pain in the US ranges from $350 million to $1.8 
billion (Leise et al., 2010), and has even reached $3-8 billion (Eslick & Talley, 2004; Eslick et 
al., 2005; Eslick, 2008; Liuzzo et al., 2005; Mant et al., 2004). In the UK, it consumes 
approximately 1% of the health care budget (Fox, 2005). However, the real costs of recurrent 
chest pain are greater because of the social expenditure connected with this symptom (Eslick 
& Talley, 2004; Eslick et al., 2005; Eslick, 2008; Katerndahl, 2004). Within the one to five-year 
follow-up period, about 40% of patients with recurrent chest pain are hospitalized at least 
once due to chest pain, 30% receive a subsequent coronary angiogram (Bugiardini et al., 
2005), nearly 30% of patients are unemployed and receive a disability pension, and in 60% of 
individuals recurrent chest pain limits their physical activity, causing displeasure regarding 
physicians’ competence in 66-81% (Dickman & Fass, 2006).  
There may be a number of reasons for unsatisfactory data concerning the prevalence and 
treatment outcome in patients with recurrent chest pain. To counter this, the many well-
known causes of chest pain episodes ought to be analysed, as they have various degrees of 
clinical importance and may originate from cardiovascular system dysfunction (due to 
myocardial ischaemia or non-ischaemic reasons), the respiratory system, digestive tract, or 
begin in the skeleton (Cayley, 2005; Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; 
Laird et al., 2004). Symptoms deriving from each of these sources may be further aggravated 
by reactions of depression or panic disorders (Dickman & Fass, 2006; Fass, 2008; Fass & 
Navarro-Rodriguez, 2008). Moreover, the respective causes of chest pain may coexist and 
overlap (e.g. the cardiovascular with the gastroenterological or musculoskeletal), and 
disorders of one system may disturb the function of the others, masking the true cause of 
symptom evoking. These complicated relationships connected with chest pain make it 
difficult to diagnose and treat the chest pain source, favour symptom recurrence, and 
increase resource utilization. Precision in the analysis of symptom characteristics remains 
the pivotal diagnostic method of chest pain origin because of the aforementioned low 
diagnostic yield of non-invasive cardiovascular examinations and elective coronarography 
(Patel et al., 2010). In particular, the localization, radiation and character of chest pain 
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episodes should be evaluated, as well as any aggravating and alleviating factors (Potts & 
Bass, 1995; Swap & Nagurney, 2005). Angina pectoris is a particular type of chest pain. It is 
defined as precordial discomfort, sometimes radiating to the jaw or arm, which is provoked 
by effort, emotional stress, cold or wind, and withdraws after rest or nitroglycerine use. 
However, too many times it is forgotten that these criteria are applicable to chest pain 
episodes originating not only from the cardiovascular system, but also from the digestive 
tract, especially from the oesophagus, stomach and gall bladder. Moreover, angina pectoris 
may be caused by myocardial ischaemia, resulting not only from coronary artery narrowing, 
but also from extracardiac disorders, which leads to an imbalance between myocardial 
oxygen supply and requirement (e.g. anaemia, thyrotoxicosis). Anaemia is frequently 
secondary to many digestive tract diseases, such as acute and/or chronic bleeding from the 
alimentary tract (erosions, ulcers, neoplasm), malabsorption, maldigestion, blood 
sequestration or autoimmunological reactions. In this way, disorders of the digestive tract 
can also favour angina pectoris exacerbation. Therefore, although certain elements of the 
chest pain history are associated with increased (radiating to shoulder(s), or arms, or 
precipitation by exertion) or decreased (pain like stabbing, pleuritic, positional, or 
reproducible by palpation) likelihoods of a diagnosis of angina pectoris, none of them alone 
or in combination identify a group of patients, who do not need a further diagnostic testing 
(Swap & Nagurney, 2005). 
To summarize, angina pectoris is an important, prevalent symptom, utilizing enormous 
quantities of resources, which is considered all too frequently as a typical symptom of 
coronary artery disease (CAD), but rarely as a symptom of at least two types of digestive 
tract disease. The first group concerns diseases which evoke angina-like chest pain from the 
oesophagus, stomach and gall bladder by the stimulation of their chemo-, mechano-, and/or 
thermoreceptors; the second group manifests clinically as anaemia, which leads to 
insufficient oxygen supply to the heart. It is important to realize that both these kinds of 
digestive tract diseases may overlap with CAD, aggravating precordial symptoms or 
mimicking atherosclerosis progression. These gastroenterological aspects of angina pectoris 
will be analysed in this chapter in detail.  
2. Epidemiology 
Coronary artery disease (CAD) is the most frequent cause of morbidity and mortality in 
developed countries. As a result of such epidemiological data, almost each chest pain 
episode is considered as originating from the heart. However, recurrent, angina-like chest 
pain originating from e.g. the oesophagus is also a frequent problem in everyday practice, 
mainly due to the high prevalence of alimentary tract diseases in the general population. 
Recurrent chest pain which is non-cardiac in origin is defined as substernal chest pain in the 
absence of significant epicardial coronary artery stenoses (Eslick & Talley, 2004; Eslick et al., 
2005; Eslick, 2008; Dickman & Fass, 2006; Fass, 2008; Hebbard, 2010; Leise et al., 2010). It is 
reported every year by about 13-30% of adults, without sex preference. It is experienced 
during a typical lifespan by approximately 20-40% of the population, with a decrease in 
prevalence with increasing age (Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; 
Dickman & Fass, 2006; Fass, 2008; Ruigómez et al., 2006, 2009). The majority of patients with 
recurrent chest pain which is non-cardiac in origin continue to report episodes of long-term 
symptoms. In the study by Potts and Bass (1995), 75% of the surviving patients with 
recurrent chest pain and lack of obstructive coronary artery lesions continued to report the 
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occurrence of precordial discomfort 11 years later, and 34% reported weekly chest pain 
symptoms.   
The most prevalent cause of non-cardiac chest pain (NCCP) is gastro-oesophageal reflux 
disease (GERD), which accounts for up to 60% of cases (Leise et al., 2010). The occurrence of 
its main symptom, heartburn, at least once per month is reported by about 36-44% of the 
adult population, 14% once per week, and 7% every day (Lemire, 1997). On the other hand, 
a chest pain sensation is experienced by about 37% of patients with heartburn occurring 
once per week, 30% of individuals with more seldom symptom occurrence, and about 8% 
without the feeling of pyrosis (Fass and Navarro-Rodriguez, 2008).  
It is generally estimated that gastroenterological abnormalities have a similar prevalence in 
patients both with and without significant coronary artery narrowing, which shows a 
possibility to overlap e.g. GERD and CAD symptoms (Budzyński et al., 2008; Budzyński 
2010a, 2010c; Cooke et al., 1998; Dobrzycki et al., 2005; Mehta et al., 1996; Ruigómez et al., 
2006, 2009; Schofield et al., 1987, 1989). Only a few authors have suggested a lower 
coexistence of oesophageal disorders in subjects with CAD (Adamek et al., 1999; Battaglia et 
al., 2005). On the other hand, the probability of diagnosing the respective functional 
oesophageal disorders (GERD, motility disorders, visceral hypersensitivity) as a cause of 
non-cardiac chest pain (NCCP) depends on the location of the patient’s consultation. They 
were the cause of non-cardiac chest pain (NCCP) in 0.6-25% of patients of general 
practitioners, in 46% of patients admitted to Cardiological Intensive Care Units because of 
acute chest pain, in 60-70% of patients with angina-like chest pain and a normal coronary 
angiogram, and in 30-80% of patients with obstructive coronary lesions and chronic precordial 
discomfort non-responsive to optimal anti-angina therapy (Budzyński et al., 2008; Dobrzycki 
et al., 2005; Rosztóczy et al., 2007; ģwiątkowski et al., 2004). Therefore, NCCP caused by 
gastrointestinal, mainly oesophageal, disorders may coexist with CAD in as many as 30-80% of 
patients. This is very high but clinically very important, as disease overlapping, which causes a 
great deal of confusion and clinical doubt, is related to at least three factors: the 
epidemiological, the pharmacological, and the pathophysiological (Budzyński et al., 2008).  
Epidemiological causes of the frequent coexistence of digestive and cardiovascular disorders 
result from a high prevalence of diseases sourced from both systems and have similar risk 
factors. Both gastroenterological and cardiovascular diseases are found more frequently in 
older and obese patients, those suffering from hypertension, diabetes, and obstructive sleep 
apnoea, as well as in smokers, alcohol drinkers and caffeine over-users (Budzyński et al., 
2008; Fass & Dickman, 2006;). The frequent coexistence of gastroenterological and 
cardiovascular diseases also depends on pharmacological causes due to the adverse effects 
of drugs recommended in the therapy for both system disorders. It is generally known that 
calcium channel antagonists (e.g. amlodipine, verapamil and diltiazem), nitrates, blockers of 
alpha-1 adrenergic receptors, and betamimetics may decrease with lower oesophageal 
sphincter (LOS) pressure and favour gastro-oesophageal reflux, the most frequent cause of 
NCCP. It should also be taken into consideration that aspirin-induced gastropathy is a 
potential cause of NCCP (Hsiao et al., 2009). Its symptoms frequently disappear after 
empirical therapy with proton pump inhibitors (PPIs), but this has not been confirmed by all 
authors. Moreover, some medicines used in the treatment of gastroenterological disorders 
may show pharmacological or pharmacodynamic interactions with drugs recommended for 
cardiovascular diseases, e.g. omeprazole decreases the bioavailability of digoxin, warfarin 
and clopidogrel. The last interaction in particular caught the investigator’s attention 
following publication by Juurlink et al. (2009), who reported a greater prevalence of acute 
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coronary syndromes and myocardial infarction in patients taking omeprazole, rabeprazole 
or lansoprazole for the purpose of preventing gastrointestinal bleeding during dual anti-
platelet therapy. Although recent publications have not confirmed the clinical importance of 
this interaction, their authors and panels of experts have recommended caution in co-
prescribing PPIs with clopidogrel (American College of Cardiology Foundation [ACCF], 
2010; American Society for Gastrointestinal Endoscopy [ASGE], 2009; Bhatt et al., 2008; de 
Aquino Lima & Brophy, 2010; Laine & Hennekens, 2010). There is also divergent 
information concerning the interaction between PPIs and acetylsalicylic acid, showing no 
effect (Adamopoulos et al., 2009), an increase (Kasprzak et al., 2009), and a decrease (Würtz 
et al., 2010) in anti-platelet aspirin activity.   
Finally, the high prevalence of the coexistence of cardiovascular and gastroenterological 
chest pain causes may also result from pathophysiological factors, mainly the inflammatory 
and neural pathways for linked angina (Chauhan et al., 1996; Hoff et al., 2010; Makk et al., 
2000; Rosztóczy et al., 2007). They are connected in the mechanism of a vicious circle, in 
which gastro-oesophageal reflux induces myocardial ischaemia, and products of the 
anaerobic myocardial metabolism due to ischaemia in turn provoke gastro-oesophageal 
reflux, dysphagia, or hiccups (Hoff et al., 2010; Krysiak et al., 2008; Stec et al., 2010). These 
problems are explained in detail in a separate subsection (4b).   
3. Prognosis  
Patients with recurrent chest pain and normal coronary angiogram (i.e. NCCP) have a 
relatively good life expectancy prognosis. The 30-day mortality connected with this 
symptom is estimated at 0.3-1.1% (Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008), the 
risk of major cardiovascular event (death, myocardial infarction) with an odds ratio (OR) 
amounting to 2.3 (95% CI, 1.3-4.1) (Ruigómez et al., 2006, 2009), and the need for emergency 
coronary intervention amounting to approximately 4% (Hollander et al., 2007). However, in 
the recent study by Leise et al. (2010), patients with NCCP which is gastrointestinal in origin 
displayed less overall survival at all time points compared with their counterparts with 
NCCP of unknown origin, specifically 70.1% at 10 years and 51.8% at 20 years. This was 
mainly explained by the overlapping of cardiovascular risk factors in patients with GERD. 
Whereas, in the paper by Munk et al. (2008), the 10-year relative risk of hospitalization for 
ischaemic heart disease (a discharge diagnosis of myocardial infarction, angina and/or heart 
failure) following a normal upper endoscopy among 386 Danish patients with unexplained 
chest/epigastric pain was 1.6 (95% CI, 1.1–2.2), compared with 3,973 population controls. 
The adjusted mortality rate ratio was the greatest within the first year after an upper 
endoscopy and amounted to 2.4 (95% CI, 1.3–4.5). The difference faded with time, and the 
10-year adjusted mortality rate ratio amounted to 1.1 (95% CI, 0.9–1.5). The increased 
mortality among these patients stemmed from alcohol dependence, pneumonia (not as a 
complication of the endoscopy), and lung cancer, but not IHD.  
On the other hand, patients with recurrent chest pain have a poor prognosis in relation to 
symptoms receding. They also present a high annual rate (50-81%) of chest pain recurrence 
(Ruigómez et al., 2006, 2009). Unemployment connected with this symptom occurrence 
concerns 41-50% of patients (Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; Fass, 2008; 
Fass & Dickman, 2006; Fass & Navarro-Rodriguez, 2008).  
The aforementioned data justify undertaking the effort to establish the most precise 
diagnosis of the source of recurrent chest pain. Such a procedure makes it possible to calm 
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the patient by explaining some of the non-dangerous reasons for chest pain occurrence. 
Moreover, the diagnosis of the real source of distressing complaints makes possible a 
specific treatment recommendation. It is effective in different degrees in about 80% of 
patients, decreasing NCCP episode recurrence and hospitalization necessity, improving 
patients’ health-related quality of life, and reducing the health care costs (Cheung et al., 
2009; Dickman & Fass, 2006; Fass, 2008; Fass & Dickman, 2006; Fass & Navarro-Rodriguez, 
2008; Laheij et al., 2003; Sheps et al., 2004). The diagnosis of GERD as a source of NCCP and 
the recommendation of the prolonged use of PPIs has decreased the risk of chest pain 
recurrence by 46% and the number of patients needing to be treated (NNT) has amounted to 
3 (95%CI, 2-4) (Cremonini et al., 2005). Whereas, undiagnosed chest pain has been shown to 
increase the risk of hospitalization due to CAD and all-cause mortality during 10 years of 
follow-up (Munk et al., 2008).  
4. Pathophysiology    
As has been mentioned, angina-like chest pain presents typical features of visceral pain 
which may be symptomatic of both ischaemic heart diseases and digestive tract disorders. 
To the first group of diseases belong both patients with coronary artery narrowing, known 
as patients with CAD, and subjects with a normal or almost normal coronary artery 
angiogram (“non-visible”, “non-obstructive atherosclerotic coronary disease” (Bataglia et 
al., 2005). Chest pain occurring in patients with a normal coronary angiogram is frequently 
called NCCP. It may be caused by extracardiac diseases, mainly digestive tract disorders 
(Labenz, 2010). However, it should also be taken into account that it may also be sourced by 
missed coronary angiogram lesions, microvascular coronary dysfunction (cardiac syndrome 
X), coronary spasm, or secondary angina (e.g. aortic valve dysfunction, tachycardia, 
thyrotoxicosis, anaemia) (Bugiardini et al., 2005).  
The relationships between the digestive tract and cardiovascular system are complicated 
and stem from epidemiological, pharmacological (described above) and pathophysiological 
factors. Each of them concerns both patients with a normal coronary angiogram and with 
CAD, and may lead to symptom mimicry and overlapping. There are at least three 
pathomechanisms evoking angina-like chest pain in the course of digestive tract diseases:  
a. chest pain is evoked by stimulation of digestive tract pain receptors and mimics angina;  
b. digestive tract diseases via neural and inflammatory pathways disturb myocardial 
perfusion and evoke chest pain which is cardiac in origin due to myocardial ischaemia, 
although the true cause of the symptoms is located e.g. in the oesophagus;  
c. chest pain, cardiac in origin, is secondary to an imbalance between oxygen supply and 
myocardial demand due to anaemia, which is frequently secondary to various diseases 
of the alimentary tract.   
4.1 Angina-like chest pain which is digestive tract in origin 
The most common example of the first pathophysiological group of chest pain is GERD, 
responsible for 50-60% of the causes of NCCP (Dickman &  Fass, 2006; Eslick & Talley, 2004; 
Eslick et al., 2005; Eslick, 2008; Fass & Dickman, 2006; Fass & Navarro-Rodriguez, 2008; 
Hebbard, 2010; Tipnis et al., 2007; Tougas et al., 2001). The main symptoms of GERD are 
heartburn (pyrosis), regurgitation, or the “reflux chest pain syndrome” distinguished by the 
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definition and classification of GERD developed by the Montreal Consensus Group in 2006 
(Vakil et al., 2006). The other diseases which may mimic angina pectoris, frequently known 
as non-GERD-related NCCP, are as follows: oesophagitis caused by non-reflux-related 
factors (such as infections or being drug induced); oesophageal motility disorders; hiatal 
hernia; gastric and duodenal ulcer disease; drug- (aspirin, non-steroidal anti-inflammatory 
drugs) induced gastropathy; acquired hepato-diaphragmatic migration of the hepatic 
flexure of the colon (Chilaiditi's syndrome); cholecystitis; and acute pancreatitis (Dickman & 
Fass, 2006; Drewes et al., 2006; Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; Fass & 
Dickman, 2006; Fass & Navarro-Rodriguez, 2008; Ruigómez et al., 2006, 2009, , Sorrentino et 
al., 2005). The Rome Criteria III also distinguish a particular kind of non-cardiac chest pain, 
called “functional chest pain of presumed esophageal origin”, which is defined as midline 
discomfort which is not of burning quality, lasting at least three months, with an onset at least 
six months prior to diagnosis, and an absence of GERD and histopathology-based oesophageal 
motility disorders (Drossman, 2006). My own observations have also shown that exercise-
induced oesophageal motility disorders, such as exercise-provoked oesophageal spasm 
(EPOS) or exercise-provoked gastro-oesophageal acid reflux, may play some role in the 
pathogenesis of angina-like chest pain in at least 22% of patients with recurrent symptoms 
(Budzyński, 2010a, 2010b). It is worth underlining that nearly 80% of the patients with 
functional chest pain simultaneously present symptoms of other functional disorders, 
primarily irritable bowel syndrome (27%) and abdominal bloating (22%) (Dickman & Fass, 
2006; Fass & Navarro-Rodriguez, 2008). Their coexistence with chest pain may help in 
appropriate diagnoses. The aforementioned mainly oesophageal and gastric abnormalities 
may be accompanied by endoscopically visible morphological changes in mucosa or not. Some 
of these differences in the clinical course of GERD have been classified by the Global 
Consensus Group in Montreal, which, among oesophageal syndromes, enumerates: (a) 
symptomatic syndromes (without oesophageal erosions) concerning approximately 60% of 
patients, and (b) syndromes with oesophageal injury (erosive oesophagitis, oesophageal 
strictures, Barrett’s oesophagus, oesophageal adenocarcinoma) (Sarkar et al., 2004; Vakil et al., 
2006). In this way, oesophageal erosions are present in 10-70% of patients with NCCP (Fass 
and Navarro-Rodriguez, 2008); therefore, a lack of endoscopic abnormalities does not exclude 
both a GERD and an oesophageal origin of NCCP.  
The above-mentioned diseases of the oesophagus, stomach, colon, pancreas or gall bladder 
evoke angina-like chest pain by the activation of local pain receptors, both chemical and 
mechanical (e.g. ASIC, TRPV, P2X and TREK), by inflammatory mediators, kinins, pepsin, 
bile acids, changes in oesophageal pH, pressure (oesophageal distension, volume, shear 
stress), or temperature, and by the induction of a secondary local motility response, 
expressed by hypermotility, oesophageal long muscle shortening, high amplitude 
oesophageal peristalsis, oesophageal distension or prolonged oesophageal contractions 
(Drewes et al., 2006; Sifrim et al., 2007; Tipnis et al., 2007). However, the intensity of the 
clinical manifestation of these disorders is related to the threshold of receptor stimulation. 
Its decrease is frequently known as visceral hypersensitivity (Dickman & Fass, 2006; Drewes 
et al., 2006; Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; Fass & Dickman, 2006; Fass 
& Navarro-Rodriguez, 2008). It is enumerated as one of the main pathomechanisms of 
symptoms in the course of cardiac syndrome X, mitral prolapse syndrome, irritable 
oesophagus, functional dyspepsia, irritable bowel syndrome (IBS), and fibromyalgia 
(Katerndahl, 2004; Hammet et al., 2003; North et al., 2007). The recently published 
investigation by Nasr et al. (2010) using a balloon distension test has shown that 
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oesophageal hypersensitivity plays an important role in 75% of patients with functional 
(non-cardiac and non-reflux) chest pain. The basis of this disorder is a decrease in the pain 
threshold, both at the central and peripheral perception levels (Dickman & Fass, 2006; Fass 
& Dickman, 2006; Sheps et al., 2004; Sifrim et al., 2007). The range of the change in this 
threshold may be modulated by a number of factors influencing the function of the brain-
gut axis (Mayer & Tillisch, 2011; Sheps et al., 2004). These factors are as follows:  
 personal (female gender, age between 15-34, incorrect response of the autonomic 
nervous system, psychiatric disorders, stress, sleep disturbances, oesophagitis or 
gastritis, mucosal mastocyte infiltration, allodynia); 
 environmental (stress, Helicobacter pylori (Hp) infection, dietary factors, especially a fatty 
diet) (Remes-Troche, 2010; Sheps et al., 2004; Sifrim et al., 2007; Tougas et al., 2001).  
The modulation of the central pain threshold in patients with unexplained chest pain, CAD 
and occult GERD may also be related to chronic receptor stimulation and/or the coexistence of 
psychiatric disorder (Drewes et al., 2006; Lenfant, 2010; Remes-Troche, 2010). Sarkar et al. 
(2004) have reported a decrease in allodynia after therapy with PPIs. Whereas, Makk et al. 
(2000) have shown a greater oesophageal acid sensitivity (a lower pain threshold) in 
individuals with a normal coronary angiogram and patients undergoing coronary angioplasty 
than in those with coronary artery narrowing and undergoing coronary angiography alone. 
Moreover, in approximately 70% of patients with NCCP, anxiety, depression or somatization 
have been observed (Dickman & Fass, 2006; Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 
2008; Fass & Dickman, 2006; Fass & Navarro- Rodriguez, 2008; Katerndahl, 2004). In these 
subjects, NCCP amelioration and a decrease in pain hypersensitivity were found after therapy 
with antidepressants such as imipramine, sertraline or trazodone in controlled and 
uncontrolled investigations (Dickman & Fass, 2006; Eslick & Talley, 2004; Eslick et al., 2005; 
Eslick, 2008; Fass & Dickman, 2006; Fass & Navarro-Rodriguez, 2008). Psychiatric disorders, 
besides decreasing the pain threshold, may also evoke chest pain by hyperventilation and 
secondary coronary arteries and/or oesophageal spasm (Chauhan et al., 1996). As a result, the 
following markers of a psychiatric basis for recurrent chest pain were proposed: atypical 
character of symptoms, female gender, younger age, a high level of anxiety, and a neurotic 
personality (Ringstrom and Freedman, 2006).  
The character of the pain occurring in the course of digestive tract diseases may be similar to 
that of acute coronary syndrome or recurrent stable angina pectoris. The simple explanation 
of this fact involves the visceral features of the pain and the anatomical localization of the 
heart and oesophagus in the chest. The latter factor causes the overlap of the head areas in 
brain sensory representations of the oesophagus and heart. However, the anatomical 
relationships between the oesophagus and the heart may produce symptoms in some more 
immediate way. Namely, the extended left atrium, due to e.g. mitral valve disease or left 
ventricle cardiac failure, may press the oesophagus, evoking changes in intra-oesophageal 
pressure, mechanical receptor stimulation or disturbance in the oesophageal passage, 
known as cardiac dysphagia or odynophagia (angina-like chest pain which is oesophageal 
in origin). These disorders may also, through pressure receptor stimulation, activate vagal 
neural reflexes leading to a decrease in myocardial perfusion (angina-like chest pain which 
is cardiac in origin), described in detail in part b of this section. On the other hand, an 
enlarged oesophagus, due to e.g. achalasia or oesophageal carcinoma, producing left atrium 
compression, may also evoke local ischaemia of the atrial muscle and/or activation of 
mechano-electrical coupling, raising the local dispersion in the functional potential of atrial 
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muscle cells and producing re-entry loops. These disorders may manifest clinically as chest 
pain or arrhythmia (Budzyński & Pulkowski, 2009; Duygu et al., 2008; Upile et al., 2006).  
To summarize, chest pain originating from the oesophagus may be similar to cardiac-
derived angina pectoris. It may be caused by activation receptors in the digestive tract and 
motor dysfunction of the oesophageal wall. The intensity of the clinical manifestation of 
these disturbances is modulated by the frequent presence of visceral hypersensitivity. These 
complicated relationships have explained the confusion and misdiagnosis often 
accompanying chest pain diagnosis.  
4.2 Angina-like chest pain which is cardiac in origin but induced by digestive tract 
disorders  
Apart from the above-mentioned resemblance of chest pain originating from the heart and 
the oesophagus, as well as the overlapping of symptoms evoked both by cardiovascular and 
alimentary tract diseases, the clinical doubts concerning the true source of chest pain, 
whether cardiac or oesophageal, are augmented by the second of the distinguishing 
pathomechanisms of chest pain caused by diseases of the digestive tract: the activation of 
neural and inflammatory pathways which in turn may decrease myocardial perfusion.  
Neural reflex loops between the heart and oesophagus have been found both in human and 
animals. Stimulation of oesophageal chemo-, mechano- and thermoreceptors, apart from 
provoking chest pain of oesophageal origin in about half (49-56%) of patients with a normal 
coronary angiogram (cardiac syndrome X), coronary artery spasm or obturative lesions in 
coronarography (patients with CAD), may also activate vagally-mediated, viscero-visceral 
neural reflexes (e.g.  cardio-oesophageal reflex) (Budzyński et al., 2008; Budzyński, 2010c; 
Charng et al., 1988; Chauhan et al., 1996; Dobrzycki et al., 2005; Drewes et al., 2006; Fass & 
Dickman, 2006; Makk et al., 2000; Manfrini et al., 2006; Rasmussen et al., 1986; Rosztóczy et 
al., 2007) or a viscero-somatic neural reflex (Drewes et al., 2006; Jou et al., 2002). The first 
reflex may evoke ischaemic chest pain, cardiac in origin, resulting from diminished 
myocardial perfusion and secondary to pre-arteriole contraction (Chauhan et al., 1996; Makk 
et al., 2000; Rosztóczy et al., 2007); the second, viscero-somatic reflex, causes an increase in 
the spinotrapezius muscle contractions both after cardiac and oesophageal receptor 
stimulation via convergent pathways in the sympathetic nerves (Jou et al., 2002). The last 
reflex is responsible for the somatic component of pain evoked by the stimulation of 
visceral, cardiac or oesophageal receptors. Moreover, afferent stimulus originating from the 
oesophagus, stomach or gall bladder may also interfere with stimulus derived from the 
heart in the spinal cord, which is a further cause of the resemblance of symptoms deriving 
both from the digestive tract and the cardiovascular system (Sheps et al., 2004).  
However, the aforementioned reflexes (neural loops) do not function in all subjects but only 
in about half  (Chauhan et al., 1996; Makk et al., 2000; Mehta et al., 1996; Rosztóczy et al., 
2007); this results from the modulation of the impulse transmission along nervous pathways 
by coexistent mental or psychiatric disorders, the balance between the sympathetic and 
parasympathetic parts of the autonomic nervous system and the threshold of receptor 
stimulation, which is decreased in patients with visceral hypersensitivity. These suggestions 
are supported by papers showing a relatively high prevalence of panic or depressive 
disorders in approximately half of patients, with both cardiovascular and digestive tract 
diseases (Lenfant, 2010). Autonomic nervous system imbalance has also been found in up to 
half of patients with functional chest pain (Nasr et al., 2010; Tougas et al., 2001), Helicobacter 
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pylori infection (Budzyński et al., 2004), functional dyspepsia, irritable bowel syndrome 
(Mayer & Tillisch, 2011), or chronic heart failure. Modulation of visceral reflex activity by 
these cofactors may cause the activity of cardio-oesophageal reflexes not to manifest 
clinically in all subjects. Dobrzycki et al. (2005) have suggested that those most susceptible to 
the clinically important effect of cardio-oesophageal reflex activity seem to be patients with 
CAD, because in this patient group even slight coronary reserve impairment may be 
clinically important. On the other hand, Rosztóczy et al. (2007), using a combination of an 
oesophageal acid perfusion test and transoesophageal Doppler echocardiographic coronary 
flow measurement, have shown that 49% of subjects presented coronary spasm in response 
to oesophageal acidification more frequently than either epicardial coronary artery disease 
or microvascular coronary disease, probably due to signs of cardio-oesophageal reflex 
activation. In the gastroenterological work-up, they had higher DeMeester scores, an 
increased number of reflux episodes, a fraction time below pH 4, and prolonged acid reflux 
episodes. These data corroborate the paper by Sarkar et al. (2004), who observed the 
reversible influence of chronic oesophageal mucosa exposure to acid on the visceral pain 
threshold, one of the mechanisms modulating visceral, vagally-mediated reflex activity. The 
importance of the role of the parasympathetic nervous system for subjects with NCCP has 
also been shown by Tougas et al. (2001). In their study, 67% of patients with a normal 
coronary angiogram presented angina-like chest pain after oesophageal acid infusion. Chest 
pain in “acid-sensitive patients” was accompanied by a higher baseline heart rate and lower 
baseline vagal activity (estimated using heart rate variability [HRV] analysis) than “acid-
insensitive patients”. During acid infusion, vagal cardiac outflow (expressed as a high 
frequency component of HRV) increased in “acid-sensitive” but not in “acid-insensitive” 
patients (Tougas et al., 2001). 
The endpoint of the aforementioned complicated influence of the nervous system on the 
interrelationships between the cardiovascular and alimentary systems is myocardial 
ischaemia, which may manifest clinically in 49-56% of patients as angina pectoris, 
arrhythmia and syncope (Chauhan et al., 1996; Cubattoli et al., 2009; Cuomo et al., 2006; 
Makk et al., 2000; Mehta et al., 1996; Rosztóczy et al., 2007). This symptomatic decrease in 
myocardial perfusion after oesophageal stimulation by acid was produced by epicardial 
coronary artery spasm (Rosztóczy et al., 2007) or by contraction of the prearterioles 
(Chauhan et al., 1996). The neural pathway for these effects (so- called linked angina) was 
proven by the lack of similar perfusion changes in heart transplant recipients (Chauhan et 
al., 1996). However, the aforementioned reflexive decrease in myocardial perfusion was 
accompanied by ischaemic electrocardiographic (ECG) changes in only a few works 
(Budzyński et al., 2008; Dobrzycki et al., 2005; Rosztóczy et al., 2007; Singh et al., 1992; 
ģwiątkowski et al., 2004).  
However, the above-described mechanism is only the first on the arc of the cardio-
oesophageal loop of feedback. The second, opposite arm of this loop may be stimulated by 
the products of anaerobic myocardial metabolism, mainly bradykinin (Caldwell et al., 1994; 
Krysiak et al., 2008), invasive cardiac manoeuvres, manipulation, coronary angioplasty 
(Makk et al., 2000) or cardiac arrhythmia (Stec et al., 2010). Such activation may lead to 
reflexive oesophageal motility disorders or a decrease in lower oesophageal sphincter (LOS) 
pressure, which facilitates gastro-oesophageal reflux occurrence, changes in oesophageal 
pH, potential reflexive activation of a cardio-oesophageal reflex and a reduction in 
myocardial perfusion (Caldwell et al., 1994). Described as reflexive, bidirectional, neuro-
hormonal mechanisms connect the pathogenesis of the digestive tract and cardiovascular 
www.intechopen.com
 
Angina-Like Chest Pain as a Symptomof Digestive Tract Disorders 
 
45 
diseases in a vicious circle. Moreover, some studies have shown that the described 
associations between oesophageal and vascular spasm may also result from myogenic 
mechanisms and may be an overall effect of smooth muscle hypercontractility, depending 
on the individual concerned (Adamek et al., 1998a, 1998b, 1999; Makk et al., 2000; Manfrini 
et al., 2006; Rasmussen et al., 1986). The myogenic component of coronary-oesophageal 
interrelationships has been suggested by the coexistence of oesophageal spasm alongside 
coronary artery spasm, hypertension, migraine and Raynaud’s symptoms.   
The occurrence of angina-like chest pain, as well as other cardiac symptoms such as 
arrhythmia, or syncope may also be secondary to inflammatory factors often deriving from 
the digestive tract. The role of inflammatory processes in cardiovascular disease 
pathogenesis has been investigated for many years. At least two mechanisms have been 
distinguished for the influence of inflammation on cardiac function: local and systemic. The 
first has been mentioned by Weigl et al. (2003), who have suggested the possibility of local 
inflammatory process propagation through the oesophageal wall producing local 
pericarditis or atrial myocarditis. These histological abnormalities can be a substrate of chest 
pain or arrhythmia (Navarese et al., 2010; Stőlberger & Finsterer, 2003). However, there is 
more to be said for the role of a systemic inflammatory response in the pathogenesis of chest 
pain which is cardiac in origin but evoked or intensified by digestive tract diseases. Systemic 
inflammatory factors known as cytokines (e.g. TNF-alpha, IL-1, IL-6) or adhesion molecules 
(e.g. VCAM-1, ICAM-1) are involved in the pathogenesis of atherosclerosis, endothelial 
dysfunction, and cardiac arrhythmia, mainly atrial fibrillation. Their synthesis may be 
stimulated in the course of many of the diseases of the alimentary tract, such as periodontal 
diseases, oesophagitis, gastritis, ileitis, inflammatory bowel diseases, liver cirrhosis, 
pancreatitis, and neoplasm (Shanker & Kakkar, 2009; Stőlberger & Finsterer, 2003). Some 
reports, including my own data, have also shown the unfavourable effect of Helicobacter 
pylori infection, not only on the course of digestive tract diseases, but also on the course of 
recurrent angina-like chest pain (Budzyński, 2011), changes in autonomic nervous system 
balance (Budzyński et al., 2004) and atherosclerosis progression (Franceschi et al., 2009). 
CagA seropositivity has been significantly and positively associated with the occurrence of 
acute coronary events, atherosclerosis progression and arrhythmia prevalence (Bunch et al., 
2008a, 2008b; Francesci et al., 2009; Miyazaki et al., 2006). The positive relationship between 
Hp infection and cardiac syndrome X (Celik et al., 2010; Eskandarian et al., 2006; Rasmi & 
Raeisi, 2009) has also been reported but not confirmed by others (Saleh et al., 2005). 
Whereas, Sandifer et al. (1996), based on the results of the EUROGAST Study Group, had 
shown a negative association between the seroprevalence of antibodies to Hp and the death 
rate from ischaemic heart disease.  
Numerous mechanisms for the influence of Hp on atherosclerosis complications have been 
suggested. They may act directly on atherosclerotic plaques, as suggested by the results of 
Kowalski et al. (2001), who revealed the presence of Hp DNA in atherosclerotic lesions and 
an increase in coronary artery diameter after microorganism eradication. It has also been 
implied that mimicry occurs between the cytotoxin-associated gene-A (CagA) antigen 
expressed by some Hp strains and the protein presented in atherosclerotic plaques 
(Franceschi et al., 2009). Hp infection, similarly to periodontal infection (Shanker & Kakkar, 
2009) or the hepatitis C virus (Ramdeen et al., 2008), may also act as one amongst a number 
of factors taking part in the mechanisms of pathogen burden through the following: non-
specific inflammatory pathway stimulation (e.g. hs-CRP increase); the induction of 
endothelial and microvascular dysfunction; an increase in adhesion molecule expression 
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(e.g. VCAM-1, ICAM-1); the over-synthesis of pro-atherogenic cytokines (e.g. IL-1 beta, IL-6, 
TNF-alpha); changes in autonomic nervous system balance (Budzyński et al., 2004; 
Budzyński, 2011; Celik et al., 2010; Rasmi & Raeisi, 2009); and the production of metabolic 
abnormalities, such as hypertriglyceridaemia, increased LDL cholesterol levels, plasma lipid 
oxidation, hyperfibrinogenaemia, altered blood coagulation and leukocytosis. The role of 
Hp infection as a cause of myocarditis and ECG changes in patients with persistent chest 
pain has also been reported (Navarese et al., 2010). Apart from the aforementioned 
mechanisms, Hp infection may also affect the occurrence of angina-like chest pain which is 
gastroenterological in origin, being one of the pathogenic factors of gastritis, gastric and 
duodenal ulcer disease. Hp infection may also play a role in GERD pathogenesis via 
impaired vagal control of LOS pressure and a decrease in the release of ghrelin, a prokinetic 
hormone (Thor & Blaut, 2006).  
The described systemic inflammatory process mediators, e.g. deriving from the digestive 
tract, could influence cardiac symptom occurrence, not only by direct action on the vascular 
wall, but also via neuroimmune- endocrine crosstalk (Collins et al., 2009; Grundy et al., 2006; 
Marques et al., 2010; Wood, 2007). Inflammation mediators, especially cytokines such as 
TNF-alpha, interleukin-1 and interleukin-6, may stimulate both the hypothalamus and brain 
stem. The outcome of the first is the activation of the pituitary-suprarenal axis, which leads 
to increased cortisol and adrenalin secretion, and of the second is sympathetic activation. 
The consequence of such neuroendocrine stimulation may be chest pain, myocardial 
infarction, arrhythmia, sudden death or an increase in intestinal permeability due to 
digestive tract ischaemia. Its effect may in turn be an increase in cytokine secretion and the 
activation of immunological cells: lymphocytes, monocytes, macrophages and granulocytes 
possessing surface receptors for a number of neuroendocrine products. These can then 
stimulate vessel walls, induce endothelial dysfunction, atherosclerotic plaque instability and 
in turn produce neuroendocrine imbalance (Marques et al., 2010; Saleh et al., 2005). In this 
way, the aforementioned relationships involve the cardiological and gastroenterological 
symptoms in the second neuroimmune-endocrine vicious circle mechanism.  
In summary, neural loops, inflammatory processes and neuroimmune-endocrine crosstalk 
activated by digestive tract disorders may be the second group, in addition to digestive tract 
abnormalities, of important factors evoking chest pain which is cardiac in origin. It may 
result from myocarditis and/or a progression or reversible reduction in myocardial 
perfusion. These processes may play a role in patients both with and without significant 
coronary artery narrowing.  
4.3 Angina-like chest pain which is cardiac in origin but secondary to anaemia caused 
by diseases of the alimentary tract  
The main cause of ischaemic heart disease and its typical symptom of angina pectoris is an 
imbalance between coronary blood supply and myocardial requirement. This shows that 
besides a decrease in blood delivery to the myocardium, angina-like chest pain may also be 
evoked or exacerbated by inadequate oxygen supply due to anaemia. Rapidly or slowly 
progressing anaemia may be a symptom of many digestive tract diseases, both of the upper 
and lower parts. It may be an effect of bleeding, malabsorption, maldigestion, blood 
sequestration or autoimmunological reactions (Zhu et al., 2010). For this reason, diagnostic 
procedures for the digestive tract, including biochemical and serological examinations, 
ultrasonography, panendoscopy, colonoscopy, and in special cases capsule endoscopy and 
single or double balloon enteroscopy, should be recommended for each male, 
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postmenopausal women, and younger females when the quantity of blood loss during 
menstruation is insufficient to explain the presence of anaemia (Zhu et al., 2010).  
However, both cardiologists and gastroenterologists should also take into account that acute 
bleeding into the digestive tract or slowly progressing iron deficiency anaemia may also be a 
symptom of the haemorrhagic complications of the anti-thrombotic therapy (e.g. aspirin, 
clopidogrel, heparin, bivalirudin, etc.) which is fundamental in the treatment of acute 
coronary syndromes and stable angina pectoris (Dai et al., 2009; Nema et al., 2008). Of these 
complications, 50% occur in the digestive tract (To et al., 2009). Prior to endoscopic 
procedures, especially with a high risk of haemorrhagic complications (e.g. polypectomy or 
mucosal resection), the risk of the discontinuation of dual anti-platelet therapy in particular 
should be estimated (ASGE, 2009; ACCF, 2010; Bhatt et al., 2008). This is very important, as 
clopidogrel withdrawal may lead to cardiac stent thrombosis in 15-40% of cases; it is 
associated with a myocardial infarct rate of 50% and a related death rate of approximately 
20% (ASGE, 2009). Therefore, in such clinical situations, consultation between cardiologist 
and gastroenterologist is needed to avoid patients being treated from a single organ 
perspective of the relative risks (cardiology vs. gastrointestinal) but with a more global 
balanced risk assessment instead to optimize patient outcomes.  
The above deliberation shows the need for accuracy in evaluating angina pectoris symptom 
pathomechanisms (primary or secondary) to avoid the iatrogenic, clinically overt or silent 
haemorrhagic complications of anti-thrombotic drugs. Misdiagnosis or the inadequate 
taking of a medical history may lead to anaemia occurrence or aggravation, an increase in 
chest pain severity, unnecessary coronary angiogram performance, or death during 
haemorrhagic shock. One potential clinical scenario may take the following course: angina 
pectoris (stable or acute coronary syndrome) + latent digestive tract disease  treatment 
with aspirin and clopidogrel and/or warfarin or heparin  haemorrhagic complications 
(clinically overt or silent)  secondary anaemia and/or haemodynamic complications  
exacerbation of chest pain severity  coronary angiogram performance, percutaneous 
coronary intervention and the need for prolonged dual anti-platelet therapy  an increase 
in the intensity of bleeding from the digestive tract, anaemia aggravation and a further 
increase in angina pectoris severity. In this way, clinically overt or latent bleeding from the 
digestive tract and secondary anaemia, besides the aforementioned neural cardio-
oesophageal loop and neuroimmune crosstalk, may be the third vicious circle mechanism, in 
which gastroenterological disorders, exacerbated or complicated by anti-platelet or anti-
thrombotic treatment, may increase angina pectoris severity.  
5. Diagnosis  
According to current opinion, all patients with chest pain should first be evaluated for a 
cardiac cause of their symptoms (Fass & Dickman, 2006; Potts & Bass, 1995). To make this 
easier, some authors recommend estimating the probability of cardiac chest pain origin on 
the basis of tests with nitroglycerine and the number of atherosclerosis risk factors. In spite 
of some doubts concerning the low specificity of a nitroglycerine test (Fass & Dickman, 
2006), chest pain disappearance within five minutes after one dose of 400 mcg of short-
acting nitrates, a cardiac or gastroenterological symptom source should be considered, 
rather than a psychiatric one. Afterwards, if the tests present more than two atherosclerosis 
risk factors, a cardiological diagnostic pathway should be taken first (an ECG, stress test, 
stress echocardiography and angiography being the proposed series of steps). However, if 
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patients have fewer than three risk factors, the following sequence of procedures in the 
diagnosis of angina-like chest pain presumed to be of oesophageal origin is proposed: 
complete the Carlsson-Dent questionnaire; empirical therapy with proton pump inhibitors 
(PPIs), known as the “omeprazole test”; endoscopy; 24-hour ambulatory oesophageal pH-
metry; 24-hour multichannel intraluminal oesophageal impedance with pH-metry 
examination, in particular with an analysis of the symptom index (SI) or symptom association 
probability (SAP); stationary oesophageal manometry; 24-hour oesophageal manometry with 
SI or SAP evaluation; brain imaging; as well as psychiatric examination (Dickman & Fass, 
2006; Eslick & Talley, 2004; Eslick et al., 2005; Eslick, 2008; Fass & Dickman, 2006; Fass & 
Navarro-Rodriguez, 2008; Hewson et al., 1990; Oranu and Vaezi, 2010; Sheps et al., 2004). The 
recently proposed diagnostic methods for NCCP presumed to be of oesophageal origin are as 
follows: a magnifying endoscopy with high resolution imaging (to show oesophageal mucosa 
microerosions), prolonged oesophageal pH-metry using the wireless Bravo method, high 
resolution manometry, high frequency intraoesophageal ultrasonography (HFIUS), impedance 
planimetry, and multi-slice computer tomography. However, their usefulness in the diagnosis 
of chest pain requires confirmation (Dickman & Fass, 2006; Fass & Dickman; George & 
Movahed, 2010; Hebbard, 2010).  
The Carlsson-Dent questionnaire (CDQ) is a simple but old diagnostic tool for the detection 
of GERD, the main cause of NCCP without alarm symptoms or the suspicion of the other 
possible GERD complications (Numans & de Wit, 2003). It has been validated in European 
patients. In comparison with oesophageal pH-metry and endoscopy, it is estimated as 
having good sensitivity (89-94%) and a positive predictive value (55-90%) for the detection 
of GERD.    
Empirical therapy with a triple standard dose of PPI (e.g. 40-0-20 mg of omeprazole) gives 
valuable information about GERD being the reason of NCCP. It is a simple, available, 
sensitive and cost-effective tool, but the specificity is insufficient to put this test into practice 
as the single objective diagnostic criterion, mainly due to risks connected with false 
undiagnosed CAD. Its sensitivity and specificity in the diagnosis of GER-related chest pain 
in comparison with oesophageal pH-metry reaches 69-95% and 57-86% respectively (Fass & 
Dickman, 2006; Dickman et al., 2005; Wang et al., 2005). However, this test may be less 
valuable for patients in whom symptoms appear less frequently than twice a week 
(Cremonini et al., 2005). On the other hand, taking this limitation into account, testing with 
PPIs can be used as a diagnostic (lasting 1-2 weeks) and as a diagnostic-therapeutic test (1-4 
months of “therapy as investigation”). Chest pain disappearance after the respective period 
should be interpreted as confirmation of clinical associations between acid regurgitation and 
symptom occurrence. The economic aspects of NCCP diagnosis also see much of the use of 
this test in clinical practice. A one-week test with PPI decreased the overall costs of NCCP 
diagnosis by $573-1,338, mainly due to the reduction in the number of panendoscopies 
performed (by 81%), 24-hour oesophageal pH-metry (by 79%), and remains the functional 
diagnostic examination for NCCP (Fass & Navarro-Rodriguez, 2008). Unfortunately, this 
test was not validated in patients with CAD, in whom GERD symptom prevalence and 
overlapping seems to be clinically important. Of this group, GERD-related chest pain 
episodes were found in 30-46% of patients (Budzyński et al., 2008; Dobrzycki et al., 2005). 
These overlapped with chest pain of cardiac origin, being indistinguishable from angina 
pectoris resulting from myocardial ischaemia and leading to symptom persistence. In the 
RITA-3 study, 24% of participants still reported angina in the II-IV class according to the 
CCS classification over one year after percutaneous coronary intervention (Kim et al., 2005; 
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Poole-Wilson et al., 2006). In light of this, such empirical testing with PPIs seems to be worth 
recommending for each patient with refractory angina. Unfortunately, the recent 
recommendation concerning refractory angina by Kones (2010) does not refer to such a 
possibility. However, due to possible potential dangerous interactions between clopidogrel 
and PPIs, this test should be avoided in patients on dual anti-platelet therapy (ACCF, 2010; 
Bhatt et al., 2008). Our own investigations have also shown the necessity for careful 
interpretation of testing with PPIs due to an increase found in nitric oxide bioavailability 
after rabeprazole therapy (Kłopocka et al., 2006) and beta-endorphin plasma levels 
(Budzyński et al., 2010). These substances produced during therapy with PPIs may mask the 
true chest pain source, including that of cardiac in origin.  
Endoscopy is the most recommendable exploratory procedure in patients with GERD 
symptoms, fundamentally heartburn and regurgitation, especially when alarm symptoms 
appear. On the other hand, 50-75% of GERD and 10-70% of NCCP patients have a normal 
endoscopy examination (non-erosive GERD) (Dickman & Fass, 2006; Fass & Dickman, 2006). 
The recent report by Dickman et al. (2007a), on the basis of the results of upper endoscopy 
undergone for NCCP and GERD in a group of respectively 3,688 and 32,981 consecutive 
patients, has shown a normal upper endoscopy in 44.1% of NCCP patients and 38.8% of 
those with GERD. Of the NCCP group, 28.6% had a hiatal hernia, 19.4% erosive 
oesophagitis, 4.4% Barrett's oesophagus, and 3.6% stricture/stenosis. Peptic ulcers were 
found in 2% of the NCCP patients. Thus, endoscopy does not appear to be dispensable in a 
large group of patients with NCCP. It is likely that the new generation of endoscopy 
equipment - magnifying endoscopy - would be helpful in the detection of oesophageal 
mucosa microerosions, but it is unable to provide certainty of the clinically important 
association between NCCP and oesophageal lesions found. Therefore, the greatest clinical 
importance of endoscopy is the possibility of diagnosis, including mucosal biopsy and 
treatment of the morphologic cause of alarm symptoms and the source of haemorrhaging 
from the digestive tract. Thus, awareness should be accompanied by the knowledge that 
normal endoscopy does not exclude a gastroenterological cause of NCCP in patients who 
also have confirmed CAD.   
Twenty-four-hour oesophageal pH-metry has been considered the most sensitive and 
specific test in the diagnosis of GERD and GER-related chest pain. Although 41-43% of 
patients with NCCP fulfilled the criteria for pathological GERD (Leise et al., 2010), a significant 
percentage of patients (about 25%) in whom symptoms corresponded with heartburn had 
rather normal results for 24-hour pH monitoring examinations (Talaie et al., 2009). This 
discrepancy resulted from the method limitation, as 24-hour oesophageal pH-metry detects 
acid reflux, and NCCP may also be provoked by the regurgitation of alkaline or neutral gastric 
content. Therefore, for NCCP diagnosis, especially in patients who are non-responsive to 
empirical therapy with PPIs, 24-hour simultaneous oesophageal impedance and pH 
monitoring seems to be more useful, mainly due to the possibility of non-acid gastro-
oesophageal reflux (GER) diagnosis (Sifrim & Blondeau, 2006; Sifrim et al., 2009). An 
additional but practically the most valuable feature of this tool is the possibility of SI and SAP 
analysis. These enable the evaluation of the relationships between symptom occurrence and 
oesophageal function disorders which are not only related to the regurgitation of hydrochlorid 
acid. Only such a proven relationship gives an acceptable probability that oesophageal 
disorders are truly the reason for recurrent symptom episodes, and has been the basis of the 
identification of “GER-related” and “non-GER-related” chest pain (Dickman & Fass, 2006; Fass 
& Dickman, 2006; Fass & Navarro-Rodriguez, 2008). One of the oldest tests estimating the 
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associations between chest pain occurrence and oesophageal acidification is the Bernstein test. 
Recently, it has not been practically applied, but formerly it was widely used, not only as a 
diagnostic tool, but primarily in scientific investigation (Chauhan et al., 1996; Makk et al., 2000; 
Rosztóczy et al., 2007; Schofield et al., 1987, 1989).  
Stationary oesophageal manometry, as well as recently introduced high resolution 
oesophageal manometry, has minor importance in NCCP diagnosis, mainly due to 
difficulties with confirming the association between chest pain episodes and motility 
disorders, and the still unsatisfactory treatment effects (Fass & Dickman, 2006; Hershcovici 
& Fass, 2010; Nam et al., 2006). However, 24-hour oesophageal function monitoring is 
potentially more useful, mainly due to the possibility of examining performance during 
patients’ everyday activity, the greater probability of symptom occurrence during 
examination and the possibility of correlating their presence with oesophageal disorders 
(using an SI index or SAP). Moreover, there is now the opportunity to evaluate oesophageal 
pH and motility correlation on the basis of a greater number of analysed parameters in 
computer software. On the other hand, the usefulness of both oesophageal pH-metry, 
impedance examination and 24-hour oesophageal manometry is restricted to patients with 
daily, or at least every two days, symptom prevalence (Singh et al., 1992). Diagnosis of an 
NCCP source using 24-hour pH-metry or manometry has been obtained in 46% of patients 
in whom symptoms occurred at least once per day and only in 11% of subjects with chest 
pain of less frequency (Janssens et al., 1986). In the study by Eslick  (2008), following 
examination of the most numerous population of patients with non-GER-related chest pain 
to have been assessed in this way, the distribution of oesophageal motility abnormalities 
was as follows: normal manometry in 70%, nutcracker oesophagus (14.4%), non-specific 
oesophageal motor disorder (10.8%), diffuse oesophageal spasm (3%), and other (1,8%). In 
other papers, nutcracker oesophagus was the most prevalent oesophageal dysmotility in 
patients with chest pain (Fass & Dickman, 2006; Fornari et al., 2008). Some authors have 
reported a greater prevalence of oesophageal motility disorders in patients admitted due to 
chest pain having a normal coronary angiogram than in patients with CAD (Adamek et al., 
1999; Battaglia et al., 2005). Whereas, it has not only been my own experience, based on 
patients non-responsive to empirical therapy with PPIs, which has shown a similar 
frequency of oesophageal dysmotility in patients both with and without significant coronary 
artery narrowing (Budzyński, 2010b; Cooke et al., 1998).  
As has been mentioned, the clinical usefulness of oesophageal motility examination does not 
seem to be of great value (Dickman & Fass, 2006; Fass & Dickman, 2006; Nam et al., 2006). 
Trials involving the provocative use of ergonovine, tensilon, bethanechol and pentagastrin, 
or oesophageal extension with a balloon have not improved diagnostic efficacy either. My 
own experience has shown the clinical usefulness of exercise-provoked oesophageal 
dysmotility diagnosis using simultaneous oesophageal manometry and ECG monitoring 
during a treadmill stress test. Some exercise-provoked oesophageal motility disorder 
appeared in 22% of patients with recurrent angina-like chest pain non-responsive to 
empirical therapy with PPIs (Budzyński et al., 2010; Budzyński, 2010a). The occurrence of 
angina-like chest pain, oesophageal acidification for more than 10 s, and increased 
simultaneous contractions above 55% during a treadmill stress test had greater than 80% 
specificity for diagnosing GER–related and non–GER–related chest pain. The practical 
message coming from these observations was that patients with recurrent chest pain, who 
did not report e.g. chest pain during a treadmill stress test, have a low (20%) probability of 
recognizing an oesophageal reason for their symptoms (Budzyński, 2010a).  
www.intechopen.com
 
Angina-Like Chest Pain as a Symptomof Digestive Tract Disorders 
 
51 
High frequency intraluminal ultrasound (HFIUS) is an available but rarely used 
examination, which makes it possible to assess the oesophageal muscle wall thickness in 
order to evaluate the longitudinal muscle contraction and oesophageal shortening in 
patients with oesophageal symptoms, including NCCP. Studies conducted using this 
technique suggest that prolonged oesophageal wall thickening can be connected with chest 
pain and heartburn episodes (Boesmans et al., 2010; Sifrim & Blondeau, 2006; Sifrim et al., 
2009). This examination has also helped to exclude oesophageal ischaemia from the 
mechanism of chest pain which is gastroenterological in origin (Hoff et al., 2010).  
The possibility of having so many gastroenterological examinations for chest pain source 
diagnoses may lead to problems with making the correct choice. The practical diagnostic 
algorithm for NCCP presumed to be oesophageal in origin has been proposed by Fass and 
Navarro-Rodriguez (2008). In all patients with a suspected gastroenterological source of 
chest pain, after the exclusion of a cardiac origin, they suggest analysing the presence of 
alarm symptoms (e.g. fever, stomach pain at night, weight loss, anaemia, and signs of 
bleeding from the digestive tract). If any of these is present, a panendoscopy should first be 
conducted and treatment should be chosen depending on the diagnosis. In patients without 
alarm signs, symptom evaluation and testing with PPIs was proposed as the first diagnostic 
step. In responders to empirical therapy, PPIs should be continued. In patients who fail this 
test, oesophageal pH-metry “on-therapy”, manometry and other gastroenterological 
investigations, including psychiatric assessment, should be considered.  
Careful application of this algorithm in patients with CAD is justified by the proven 
overlapping of oesophageal chest pain sources in about 30-46% of patients with CAD and 
cardiac syndrome X (Budzyński et al., 2008; Dobrzycki et al., 2005; Hewson et al., 1990; 
Oranu & Vaezi, 2010; Singh et al., 1992). Moreover, about 20% of all myocardial ischaemia 
episodes in patients with CAD correlated with pathological acid gastro-oesophageal reflux 
episodes, and were recognized as reflexive myocardial silent ischaemia or ischaemic cardiac 
chest pain due to cardio-oesophageal reflex activation (Dobrzycki et al., 2005). In light of 
these neurally-mediated cardio- oesophageal interrelationships, a comparison of the 
coronary reserve in a non-invasive evaluation before and after empirical therapy with PPIs 
seems to be worth recommending in stable CAD patients, before the next coronarography 
performance. A decrease in the signs of myocardial ischaemia after one- or two-week-long 
therapies with PPIs may help to recognize exacerbation of myocardial ischaemia due to 
oesophageal chemo- receptor activation, which is possible in about half of patients with 
CAD or cardiac syndrome X (Budzyński et al., 2008; Chauhan et al, 1996; Rosztóczy et al., 
2007; ģwiątkowski et al., 2004). In non-responders to PPI therapy, similarly to patients with 
NCCP, endoscopy, oesophageal impedance with pH-metry, oesophageal manometry with 
or without exercise provocation, as well as psychiatric examination, might be helpful (Fass 
& Navarro- Rodrigues, 2008; Katerndahl, 2004).   
6. Treatment  
Once the accurate diagnosis of the source of angina-like chest pain has been established, a 
specific therapy should be recommended. If recurrent chest pain originates only from the 
heart, due to either ischaemic cardiac or non-ischaemic cardiac disease, typical anti-angina 
pharmacotherapy and/or myocardial revascularization should be recommended, taking 
into account the results of the Clinical Outcomes Utilizing Revascularization and Aggressive 
Drug Evaluation (COURAGE) trial. In patients with refractory angina diagnosed as cardiac 
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in origin, a number of methods have been proposed (Kones, 2010). They are as follows: 
percutaneous myocardial laser revascularization (PMLR) (McGillion et al., 2010); spinal cord 
stimulation (SCS) (Lanza et al., 2011); enhanced external counterpulsation (EECP); 
percutaneous application of low frequency ultrasound, i.e. mechanical shock waves with 
ECG gating; angiogenesis stimulation by the VEGF gene and CD34+ stem cell therapy; etc.  
Individuals with angina-like chest pain with normal coronary angiogram and patients with 
CAD and overlapping gastroenterological symptoms may achieve symptomatic 
improvement after therapy oriented to oesophageal disorders (Phan et al., 2009). Such 
therapy may consist of long-term treatment with PPIs, therapy with calcium antagonists 
(Budzyński, 2010a; Budzyński et al., 2010), Helicobacter pylori eradication (Budzyński, 2011), 
as well as tricyclic antidepressants (Eslick, 2008; Fass, 2008; Fass & Navarro-Rodriguez, 
2008), selective serotonin reuptake inhibitors (citalopram, sertaline) or trazodone (Broekaert 
et al., 2006). Recent studies have also indicated the favourable effect of theophylline (Rao et 
al., 2007), botulinum toxin (Achem, 2008; Fass & Navarro-Rodriguez, 2008), acupuncture 
(Dickman et al., 2007b; Macpherson and Dumville, 2007; Pfab et al., 2011), melatonin due to 
its positive cardiological and gastroenterological action (Dominiguez-Rodriguez et al., 2009; 
Konturek et al., 2008; Pereira, 2006), hypnotherapy (Jones et al., 2006; Palsson and 
Whitehead, 2006), transcutaneous electrical nerve stimulation (TENS) (Borjesson et al., 1998), 
oesophageal dilatation, oesophagomyotomy and Nissen fundoplication (Achem, 2008; 
Dickman & Fass, 2006; Phan et al., 2009).  
The outcome of long-term therapy with PPIs in patients with NCCP has been widely 
studied (Bautista et al, 2004; Cremonini et al., 2005, 2010; Dickman et al., 2005; Dickman & 
Fass, 2006; Liuzzo et al., 2005; Wang et al, 2005). These drugs have shown a favourable effect 
in 80% of patients with “GER-related” chest pain (Dickman & Fass, 2006). The relative risk 
reduction for continued chest pain after PPI therapy was 0.54 (95% CI, 0.41-0.71), with an 
NNT amounting to 3 (Cremonini et al., 2005). The recent meta-analysis by Cremonini et al. 
(2010) has also shown an advantage with therapy using a PPI over a placebo with an odds 
ratio of 3.75 (95% CI, 2.78-4.96), as well as a high placebo response amounting to 18.85% 
(range 2.94%-47.06%). Successful therapy with PPIs is most likely in patients with a GERD 
diagnosis (Gąsiorowska et al., 2009; Oranu & Vaezi, 2010; Seo et al., 2010). Among these 
subjects, acid exposure time (AET), symptom association probability (SAP), and the 
symptom index (SI) obtained from 24-hour oesophageal pH-metry or 24-hour oesophageal 
impedance with pH analysis are considered the predictors of a favourable therapeutic 
outcome (Kushnir et al., 2010).  
Until now, there have only been a few works evaluating the role of therapy with PPIs in 
patients with CAD and recurrent chest pain suspected to be non-cardiac in origin and 
overlapping ischaemic, cardiac-derived chest pain (Budzyński et al., 2008; Dobrzycki et al., 
2005; Liuzzo et al., 2005; Mehta et al., 1996; ģwiątkowski et al., 2004). All of them, including 
our own work, have evidenced a decrease in chest pain severity and amelioration in health-
related quality of life estimated using the SF-36 survey, as well as an improvement in ECG 
signs of myocardial ischaemia, both during a treadmill stress test (a reduction in subject 
percentage with a significant decrease in ST interval during the stress test) and during 24-
hour ECG Holter monitoring (a decrease in the number of ST-segment depression episodes 
and total duration of ischaemic episodes-total ischaemic burden) after therapy with PPIs. 
Liuzzo et al. (2005), studying a veteran patient population with documented CAD, showed 
through multivariate analysis and proton pump inhibitor therapy that they could 
independently predict a significant reduction in the prevalence of patients experiencing 
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chest pain (OR = 0.09), emergency department visits (OR = 0.15), and hospitalization (OR = 
0.14) for chest pain. On the other hand, our own results have shown that the mentioned 
favourable PPI effect on the angina pectoris course in patients with CAD should be carefully 
interpreted because it might not only result from the decrease in cardio-oesophageal reflex 
activation and therapy with aspirin-induced gastropathy, but also from the increase in nitric 
oxide bioavailability observed after therapy with rabeprazole in an open-label trial 
(Kłopocka et al., 2006), as well as the increase in the beta-endorphin plasma level revealed 
for omeprazole in a randomized, double-blind, placebo-controlled, crossover study 
(Budzyński et al., 2010).  
As has been mentioned, besides a decrease in oesophageal acid exposure time and a 
reduction in GER-related myocardial ischaemic episodes, PPIs may also improve the course 
of angina-like chest pain by the alleviation of symptoms related to gastric disease (gastric 
and duodenal ulcer disease), by preventing and treating aspirin-induced gastropathy, as 
well as by reducing the risk of haemorrhagic complications from the upper part of the 
digestive tract and the prevention of secondary anaemia (ACCF, 2010; Bhatt et al., 2008; 
Hsiao et al., 2009). Tailored PPI prescription should prevail over the generalized in their 
recommendation for use with patients on dual anti-platelet therapy because of reported and 
still not definitely excluded potentially life-threatening interactions between PPIs and anti-
platelet drugs (clopidogrel, aspirin). Pantoprazole or esomeprazole should be chosen for 
gastroprotection or time intervals between respective medicines should be recommended 
(ACCF, 2010; Bhatt et al., 2008). The easiest method for the last option is the 
recommendation of PPIs in the morning and clopidogrel in the evening.  
In patients with recurrent chest pain and GERD diagnosed using oesophageal 
pH/impedance monitoring and non-responsive to PPIs, many other kinds of therapy have 
been proposed, including the following: doubling the PPI dose, switching to another PPI, 
adding histamine type 2-receptor antagonists at night, baclofen recommendation, as well as 
laparoscopic or open surgery (Dickman & Fass, 2006; Hershcovici & Fass, 2010; Kushnir et 
al, 2010; Oranu & Vaezi, 2010; Labenz, 2010). The exclusion of eosinophilic oesophagitis in 
patients with NCCP and aged under 45, atopy or dysphagia might also be helpful (Garcia-
Compeăn et al., 2011). Dickman et al. (2007b) found acupuncture added to a single dose of 
PPI to be more effective than doubling the proton pump inhibitor dose in controlling GERD-
related symptoms in patients who had failed with standard dose proton pump inhibitors.  
Calcium antagonists, such as verapamil, diltiazem, nifedipine and amlodipine, have mainly 
been used in therapy for NCCP due to hypertensive oesophageal motility disorders 
diagnosed using stationary manometry (Dickman & Fass, 2006; Fass & Navarro-Rodriguez, 
2006). The reported effects of these drugs in patients with recurrent angina-like chest pain 
were ambiguous. Some studies have shown a favourable outcome for this group of drugs, 
some have not confirmed it (Dickman & Fass, 2006; Eslick et al., 2005; Eslick, 2008; Fass & 
Dickman, 2006). Our own, recently published investigation has shown that patients with 
recurrent angina-like chest pain non-responsive to treatment with PPIs and an established 
diagnosis of exercise-provoked oesophageal spasm (EPOS), for whom a calcium antagonist 
was recommended due to exercise-provoked oesophageal spasm, had a significantly lower 
risk of hospitalization due to suspected acute coronary syndrome in the 2.7-year follow-up 
period than the remaining patients (NNT = 3.5) (Budzyński et al., 2010). In my own work it 
has been documented that Hp eradication had a similar favourable outcome (NNT = 2.7) 
(Budzyński, 2011). The rationales behind this therapy were the above-cited role of this 
infection in chest pain pathogenesis both cardiac and gastroenterological in origin.  
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Psychiatric disorders and anxiety focusing on the heart are common in patients with NCCP 
(Achem, 2008; Dickmann & Fass, 2006; Fass & Navarro-Rodriguez, 2008; Katerndahl, 2004). 
They may act as individual factors or via the increase in visceral hypersensitivity. Some 
studies have shown oesophageal motility abnormalities as markers of depressive or panic 
disorders. The last were found in 80% of patients with NCCP and oesophageal motor 
dysfunction and in 30% of subjects with a normal coronary angiogram and oesophageal 
examinations (Dickman & Fass, 2006). Eslick et al. (2005) have even recommended empirical 
therapy with tricyclic antidepressants in patients with recurrent chest pain non-responsive 
to PPIs. The rationale behind such a recommendation is that antidepressants act as pain 
modulators. In patients with NCCP, behaviour therapy involving trazodone, imipramine, 
amitriptyline, nortriptyline, citalopram, desipramine and sertraline was used for this 
purpose (Broekaert et al., 2006; Eslick, 2008; Fass, 2008; Fass & Navarro-Rodriguez, 2008). 
Their clinical efficacy was confirmed both in uncontrolled and in randomized, placebo-
controlled trials. However, the prescribing of these drugs should always be carried out 
carefully, because of the potential cardiovascular risk of tricyclic antidepressants connected 
with their adverse effects, such as prolonged QT intervals, hypertension, postural 
hypotension, and effects on heart rate variability (Hamer et al., 2011). Probably because of 
this, non-pharmacological methods which could potentially be efficient in subjects with 
NCCP have been investigated, such as hypnotherapy, behaviour therapy, and acupuncture 
(Dickman et al., 2007b; Pfab et al., 2011; Yin and Chen, 2010; Zhang et al., 2010). 
Acupuncture has had a favourable effect on gastric emptying, oesophageal motility, and in 
patients with GERD, a potential substrate of non-cardiac chest pain. In the study by 
Macpherson and Dumville (2007), 42% of the patients investigated with a diagnosis of 
NCCP made in a Rapid Access Chest Pain Unit reported that they would consider 
acupuncture, 36% reported that they would not, and 22% did not know. Moreover, in the 
pilot study by Gąsiorowska et al. (2009), a favourable effect of 18 Johrei sessions (a kind of 
meditation) during six weeks in comparison to waiting-list control patients with functional 
chest pain was found. The clinical outcome of the mentioned methods is, among other 
things, explained by a decrease in visceral hypersensitivity, for which one of the mediators 
may be endogenous opioids, one of the potential pathways of the effect of PPIs (Budzyński 
et al., 2010). However, it should be checked for each patient as to whether his or her panic or 
depressive symptoms are the true cause of chest pain recurrence or its cofactor, and not an 
effect of symptom duration chronicity and the lack of an appropriate diagnosis.  
However, particularly in populations with high cardiovascular risk, the appropriate control 
of cardiovascular risk factors is very important in therapy for patients with angina-like chest 
pain. The recent study by Leise et al. (2010) has shown that patients with recurrent angina-
like chest pain which is gastroenterological but unknown in origin (NCCP-U), in spite of 
generally being considered as having low cardiac morbidity and mortality, may ultimately 
show a higher cardiovascular and non-cardiovascular death risk. In this analysis, whose 
results should still be interpreted with limitations, the NCCP group with a diagnosis of 
gastrointestinal disorder displayed less overall survival at all time points, specifically 70.1% 
at 10 years and 51.8% at 20 years, compared with their NCCP-U counterparts. The 
independent death risk factors in adjusted univariate analysis using Cox’s proportional 
hazards model were as follows: age, the Charlson comorbidity index, previous CABG, and 
previous valvular disease. No specific cardiac or gastroenterological tests or their absence 
was associated with mortality. The authors explain their observations by the effect of the 
coexistence of gastroenterological disorders with latent non-ischaemic cardiovascular 
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disease, coronary artery spasm (Charng et al., 1988; Makk et al., 2000; Manfrini et al., 2006; 
Rasmussen et al., 1986), microvascular disease (cardiac syndrome X) or at least endothelial 
dysfunction. An important aspect might also be an overlapping of risk factors for both 
systems’ diseases, such as obesity, obstructive sleep apnoea, hypertension, smoking, and 
diabetes mellitus.  
On the other hand, the study by Leise et al. (2010) has also shown that proper management 
of patients with recurrent chest pain which is extracardiac in origin is still a great challenge 
for physicians. During a 20-year follow-up period since an initial visit to an emergency 
department due to a recurrent chest pain experience, 49% of patients sought subsequent 
care from the emergency department, 42% had repeated cardiology evaluations, and only 
15% were seen by a gastroenterologist. Thirty-eight percent underwent oesophago- 
gastroduodenoscopy, but very few underwent manometry or a pH probe.  
7. Study limitations 
The main limitations concerning investigations on the pathogenesis, diagnosis and 
treatment for patients with recurrent angina-like chest pain, both in patients with and 
without significant coronary artery narrowing, have been the small number of subject 
groups, which on average included a little over 100 participants. Only in three studies were 
the subject groups larger. The other limitations have involved the lack of or a short follow-
up period, recommendations of different medication and their doses, non-homogeneous 
definitions of oesophageal disorders, the establishment of different study endpoints, and 
only single-centre experience presentations.    
8. Future research  
Further studies should validate the test of empirical therapy with PPIs in patients with 
CAD. It would also be significant if the mechanisms for the visceral hypersensitivity leading 
to a decrease in the chest pain threshold could be identified. The evaluation of some new 
diagnostic methods, including analysis for cerebral evoked potentials, would also be useful. 
Moreover, it seems to be important to check once more and re-evaluate the appropriate 
indications for coronary angiography, both because of its costs and its inseparable exposure 
to procedure-connected health risks and substantial radiation. All the recommended 
examinations, both cardiological and gastroenterological, should be connected with precise 
investigations into cardio-oesophageal and other vagally-mediated reflexes and on the 
determination of factors predicting their clinical importance. New therapeutic methods for 
recurrent angina-like non-cardiac chest pain should also be investigated, although critical 
analysis of relationships between benefits and costs should be performed.    
9. Conclusions 
 Angina-like chest pain is a common problem in health care because of its prevalence, 
diagnostic difficulties, resource utilization and potential connection with a reduced 
health-related quality of life and shorter survival times. This symptom is conditioned by 
biological, psychological and social factors.  
 Angina pectoris may be caused by diseases of the cardiovascular system, digestive tract, 
and other extracardiac disorders which lead to an imbalance between myocardial blood 
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supply and oxygen requirement (e.g. anaemia or thyrotoxicosis). In respective patients, 
potential chest pain causes may overlap and influence each other. Therefore, NCCP 
may be present in patients both with and without heart diseases. However, the main 
and first purpose of its diagnostic procedures should be to exclude potentially life-
threatening origins.   
 Digestive tract diseases may cause angina-like chest pain along at least three pathways. 
Chest pain may originate from: (1) the oesophagus, stomach or gall bladder, due to 
stimulation of their chemo-, mechano-, and/or thermoreceptors; (2) the heart due to 
activation of cardio-oesophageal neural reflexes and secondary diminished myocardial 
perfusion; as well as (3) the heart due to a decrease in myocardial oxygen supply in the 
course of anaemia, secondary to acute or chronic alimentary tract bleeding, 
malabsorption, maldigestion, blood sequestration or autoimmunological reactions. 
Helicobacter pylori infection may play a role in all of these mechanisms.  
 The misdiagnosis of cardio-oesophageal interrelationships may lead to the progressive 
acceleration of the course of the disorders of both systems and the intensity of their 
symptoms. This occurs in at least three vicious circle mechanisms: neural, inflammatory 
(neuro-immune crosstalk), and the haemorrhagic complications of anti-thrombotic 
drugs expressed as anaemia.  
 The most frequent causes of NCCP are as follows: GERD, oesophageal motility 
disorders and panic abnormalities. Their diagnosis needs many times to use more 
advanced and more specialized diagnostic methods than panendoscopy, such as 
oesophageal impedance, pH-metry, manometry, or endosonography.  
 In the diagnosis of recurrent chest pain of possible oesophageal origin, the most 
important factor is to confirm the relationship between chest pain episode occurrence 
and oesophageal disorders. Such a possibility is provided by the test of empirical 
therapy using PPIs (the “omeprazole test”) and, in non-responsive cases, 24-hour 
oesophageal pH-metry, impedance or manometry with SI or SAP analysis. These help 
to recognize the source of chest pain in 40-80% of patients.  
 The usefulness of exercise-provoked oesophageal disorders, such as exercise-provoked 
gastro-oesophageal reflux or oesophageal spasm, needs to be evaluated. Any further 
investigations need also to estimate the interrelationships between the course of 
cardiovascular and gastroenterological tests as predictors of false positives in their 
outcomes.  
 Therapy for recurrent, angina-like chest pain should be based on the detailed diagnosis 
of its origin (whether cardiac or extracardiac), an assessment of its possible influence on 
myocardial perfusion, and the control of cardiovascular risk factors.  
 Modern cardiac and gastrointestinal diagnostic methods would probably help to better 
recognize NCCP pathophysiology, facilitating its diagnosis and treatment. However, 
they will need to be critically evaluated, not only in relation to potential clinical 
usefulness, but also in accordance with risk-benefit and benefit-cost ratios. 
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